Pale Fire Capital SE’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,444,647
Closed -$5.35M 73
2025
Q3
$5.35M Buy
1,444,647
+1,349,005
+1,410% +$3.68M 0.59% 17
2025
Q2
$187K Buy
95,642
+50,000
+110% +$104K 0.02% 49
2025
Q1
$80.3K Buy
45,642
+6,642
+17% +$15.1K 0.01% 52
2024
Q4
$104K Buy
+39,000
New +$100K 0.02% 43

Other funds holding NUVB

Pale Fire Capital SE's NUVB Position: Q4 2025 in Review

Pale Fire Capital SE sold out of Nuvation Bio (NUVB) in Q4 2025, closing a stake of 1,444,647 shares — an estimated $5.35M sold.

Pale Fire Capital SE first reported a position in NUVB in Q4 2024 and held it in 4 quarters. The position peaked at $5.35M in Q3 2025. 223 funds tracked by Wall St. Rank hold NUVB as of Q4 2025.

  • Pale Fire Capital SE reported no remaining Nuvation Bio position as of Q4 2025 after selling out during the quarter.
  • Pale Fire Capital SE sold 1,444,647 Nuvation Bio shares in Q4 2025, an estimated $5.35M.
  • Pale Fire Capital SE first reported a position in Nuvation Bio in Q4 2024 and held it in 4 quarters.
  • Pale Fire Capital SE's Nuvation Bio position peaked at $5.35M in Q3 2025.
  • 223 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2025.

Based on Pale Fire Capital SE's 13F filing for Q4 2025, filed 13 Feb 2026.